Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine

A 62-year-old woman who underwent surgery to treat pancreatic cancer provided written, informed consent to undergo adjuvant therapy with gemcitabine, tegafur, and uracil. However, this was stopped after only 14 days due to Grade 4 neutropenia. She was then started on vaccine therapy with Survivin 2B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Shima, Hiroaki, Kutomi, Goro, Satomi, Fukino, Imamura, Masafumi, Kimura, Yasutoshi, Mizuguchi, Toru, Watanabe, Kazue, Takahashi, Akari, Murai, Aiko, Tsukahara, Tomohide, Kanaseki, Takayuki, Hirohashi, Yoshihiko, Iwayama, Yuji, Tsuruma, Tetsuhiro, Kameshima, Hidekazu, Sato, Noriyuki, Torigoe, Toshihiko, Takemasa, Ichiro
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6182403/
https://ncbi.nlm.nih.gov/pubmed/30069687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2217-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados